Can early-life antibiotic exposure predict long-term immune health?

Which immune conditions are most clearly linked to early antibiotics?

The strongest and most consistent evidence points to an increased risk of asthma and atopic dermatitis (eczema). A large Australian study of over 4,300 children found that any antibiotic use in the first two years of life more than doubled the odds of developing early-persistent asthma (odds ratio 2.3) [4]. Similarly, a Swedish nationwide study of over 720,000 children reported that antibiotics during the first year raised the risk of atopic dermatitis by 52% (hazard ratio 1.52) [5]. A smaller UK study confirmed that infant antibiotic use was linked to a 59% higher odds of eczema at 12 months (adjusted odds ratio 1.59) [6].

For autoimmune diseases, a large Finnish study of over 45,000 vaginally delivered children found that antibiotics given to the mother during labor were associated with a 28% higher risk of any autoimmune disease diagnosis in the child (hazard ratio 1.28) [1]. This translates to about 22% of autoimmune cases in that population being theoretically attributable to intrapartum antibiotics.

The evidence for asthma is further supported by a Danish birth cohort study of over 32,000 children, which found that antibiotics during the second or third trimester of pregnancy increased the odds of childhood asthma by 34% (odds ratio 1.34) in vaginally delivered children [2]. Notably, no such association was seen for antibiotics given in the first trimester or for children born by cesarean section.

How big is the risk, and who is most affected?

The increased risk is modest in absolute terms. For example, in the Finnish study, the 28% higher hazard for autoimmune diseases means that among 100 children exposed to intrapartum antibiotics, about 1–2 extra cases of autoimmune disease might occur compared to unexposed children (the baseline risk is low). The 52% higher risk of eczema in the Swedish study similarly represents a small absolute increase because eczema is common but still affects only a minority of children.

Timing matters. Antibiotics given in mid-to-late pregnancy (second and third trimesters) appear more harmful than those given early in pregnancy [2]. Antibiotics given directly to the infant in the first year of life show stronger and more consistent associations than prenatal exposure alone [5][6]. The type of antibiotic may also matter: one study found that second-generation cephalosporins and beta-lactams (other than cephalosporins or macrolides) were linked to a 2.7-fold and 2-fold higher risk of persistent asthma, respectively [4].

Mode of delivery may modify the effect. The Danish study found that the asthma risk from prenatal antibiotics was only seen in vaginally delivered children, not in those born by cesarean section [2]. This suggests that disruption of the infant's gut microbiome—which is seeded during vaginal birth—may be a key mechanism.

What are the caveats? Can we be sure antibiotics cause these problems?

No, we cannot be certain that antibiotics directly cause these immune conditions. Several studies highlight that the association may be partly due to 'confounding by indication'—meaning the infections for which antibiotics are prescribed might themselves increase immune risk, or that shared family factors (genetics, environment) play a role. For example, the Swedish study on atopic dermatitis found that when they compared siblings (who share family factors), the risk from prenatal antibiotics disappeared entirely (hazard ratio 0.96), and the risk from infant antibiotics dropped from 52% to 24% [5]. This suggests that about half of the observed association is due to shared family factors, not the antibiotics themselves.

Another Italian study of over 73,000 children found no significant association between early antibiotic exposure and atopic dermatitis after accounting for 'protopathic bias'—the possibility that antibiotics were prescribed for early symptoms of eczema itself, rather than causing it [7]. When they looked at a time lag between antibiotic prescription and eczema diagnosis, the risk progressively decreased, supporting this bias.

Additionally, a Korean study of nearly 1.85 million children found that early antibiotic exposure was linked to a very small increase in developmental delays (odds ratio 1.03), but the effect was so small it may not be clinically meaningful [3]. This study also found a dose-response relationship (more antibiotics = higher risk), which strengthens the case for a causal link, but the absolute effect remains tiny.

In summary, while the evidence consistently shows a modest association between early-life antibiotics and later immune problems, the effect is not large, and part of it may be due to the underlying infection or family factors rather than the antibiotics themselves. The strongest evidence is for asthma and eczema, with weaker evidence for autoimmune diseases and developmental outcomes.

About These Sources

This answer is built on 7 peer-reviewed studies — published from 2021 to 2025, 2 from 2024 or later, 6 in Q1 journals, collectively cited 101 times — selected as the most relevant from 7 studies that passed quality screening, drawn from 64 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions